Login to Your Account



Eisai Buying AkaRx for $255M; Gaining Phase II Drug for ITP

By Trista Morrison


Monday, December 21, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription